Market Closed

NNNN
Anbio Biotechnology Class A Ordinary Shares
$ 3.82
0.53%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Anbio Biotechnology Class A Ordinary Shares News

Latest Anbio Biotechnology Class A Ordinary Shares Stock News & NNNN Headlines

Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Head-To-Head Review
8 months ago | defenseworld.net
Head-To-Head Contrast: Oncocyte (NASDAQ:IMDX) vs. Anbio Biotechnology (NASDAQ:NNNN)
8 months ago | defenseworld.net
Head-To-Head Analysis: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN)
8 months ago | defenseworld.net
Financial Comparison: Anbio Biotechnology (NASDAQ:NNNN) and Oncocyte (NASDAQ:IMDX)
8 months ago | defenseworld.net
Analyzing Anbio Biotechnology (NASDAQ:NNNN) & Oncocyte (NASDAQ:IMDX)
8 months ago | defenseworld.net
Anbio Biotechnology (NASDAQ:NNNN) vs. Oncocyte (NASDAQ:IMDX) Financial Comparison
8 months ago | defenseworld.net
Financial Analysis: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN)
8 months ago | defenseworld.net
Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) Critical Analysis
8 months ago | defenseworld.net
Reviewing Anbio Biotechnology (NASDAQ:NNNN) & Oncocyte (NASDAQ:IMDX)
8 months ago | defenseworld.net
Anbio Biotechnology (NASDAQ:NNNN) vs. Oncocyte (NASDAQ:IMDX) Critical Comparison
8 months ago | defenseworld.net
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

NNNN
Anbio Biotechnology Class A Ordinary Shares
$ 3.82
0.53%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago